Is PGTK or JNJ a better dividend investment in 2026?

PGTK currently yields 222222.22% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: PGTK offers higher current income.

What is the dividend yield difference between PGTK and JNJ?

PGTK has a forward dividend yield of 222222.22% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 222220.08 percentage points.

Home › Compare › PGTK vs JNJ

PGTK vs JNJ: Dividend Comparison 2026

PGTK yields 222222.22% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PGTK wins by $1.4076447531278624e+30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PGTK

● Live price

222222.22%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.4076447531278624e+30M

Annual income

$1,406,399,782,569,334,400,000,000,000,000,000,000.00

Full PGTK calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — PGTK vs JNJ

📍 PGTK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PGTK	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PGTK + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PGTK pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PGTK

Annual income on $10K today (after 15% tax)

$18,888,888.89/yr

After 10yr DRIP, annual income (after tax)

$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, PGTK beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PGTK + JNJ for your $10,000?

PGTK: 50%JNJ: 50%

100% JNJ50/50100% PGTK

Portfolio after 10yr

$7.038223765639312e+29M

Annual income

$703,199,891,284,667,200,000,000,000,000,000,000.00/yr

Blended yield

99.91%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PGTK

No analyst data

Altman Z

-5.9

Piotroski

0/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PGTK buys

JNJ buys

No recent congressional trades found for PGTK or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPGTKJNJ

Forward yield	222222.22% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1.4076447531278624e+30M	$30.5K ✓
Annual income after 10y	$1,406,399,782,569,334,400,000,000,000,000,000,000.00 ✓	$4,749.88
Total dividends collected	$1.4075632434891558e+30M	$15.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PGTK vs JNJ ($10,000, DRIP)

Year	PGTK Portfolio	PGTK Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$22,232,922	$22,222,222.22	$10,594	$274.49	+$22.22M → PGTK
2	$46,198,082,523	$46,174,293,296.41	$11,294	$360.69	+$46198.07M → PGTK
3	$89,718,752,943,223	$89,669,320,994,923.30	$12,133	$476.91	+$89718752.93M → PGTK
4	$162,845,393,609,755,680	$162,749,394,544,106,430.00	$13,156	$635.42	+$162845393609.74M → PGTK
5	$276,249,735,879,778,500,000	$276,075,491,308,616,120,000.00	$14,432	$854.61	+$276249735879778.50M → PGTK
6	$437,989,462,258,048,500,000,000	$437,693,875,040,657,100,000,000.00	$16,056	$1,162.76	+$437989462258048512.00M → PGTK
7	$649,026,142,700,674,900,000,000,000	$648,557,493,976,058,700,000,000,000.00	$18,175	$1,604.53	+$649026142700674875392.00M → PGTK
8	$898,874,153,179,794,200,000,000,000,000	$898,179,695,207,104,400,000,000,000,000.00	$21,009	$2,252.68	+$8.988741531797941e+23M → PGTK
9	$1,163,523,886,474,633,300,000,000,000,000,000	$1,162,562,091,130,731,000,000,000,000,000,000.00	$24,911	$3,229.73	+$1.1635238864746333e+27M → PGTK
10	$1,407,644,753,127,862,300,000,000,000,000,000,000	$1,406,399,782,569,334,400,000,000,000,000,000,000.00	$30,458	$4,749.88	+$1.4076447531278624e+30M → PGTK

PGTK vs JNJ: Complete Analysis 2026

PGTK — Stock

Pacific Green Technologies Inc. acquires, develops, and markets emission control technologies in North America, Europe, and Asia. The company offers ENVI-Clean, a system that removes sulfur dioxide, particulate matters, greenhouse gases, and other hazardous air pollutants; and ENVI-Pure, which removes acid gases, particulate matter, dioxins, VOCs, and other regulated hazardous air pollutants from the flue gases produced by the combustion of coal, biomass, municipal solid waste, diesel, and other fuels. It also provides ENVI-Marine, a scrubber for application in diesel exhaust emissions. The company was incorporated in 1994 and is based in Dover, Delaware.

Full PGTK Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this PGTK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PGTK vs SCHD PGTK vs JEPI PGTK vs O PGTK vs KO PGTK vs MAIN PGTK vs ABBV PGTK vs MRK PGTK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.